Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
      • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
JIM

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising

Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study

L Parker Gregg, Peter N Van Buren, David J Ramsey, Amaris Maydon, Subhash Banerjee, Carl P Walther, Salim S Virani, Wolfgang C Winkelmayer, Sankar D Navaneethan, S Susan Hedayati
DOI: 10.1136/jim-2022-002467 Published 3 October 2022
L Parker Gregg
1 Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
2 Medical Care Line, Section of Nephrology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
3 Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L Parker Gregg
Peter N Van Buren
4 Internal Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
5 Medical Service, Renal Section, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter N Van Buren
David J Ramsey
3 Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amaris Maydon
6 Mental Health Service, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Subhash Banerjee
7 Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
8 Medical Service, Cardiology Section, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl P Walther
1 Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salim S Virani
3 Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA
9 Internal Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas, USA
10 Internal Medicine, Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang C Winkelmayer
1 Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sankar D Navaneethan
1 Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
2 Medical Care Line, Section of Nephrology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
3 Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA
11 Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Susan Hedayati
4 Internal Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 70 no. 7 1520-1528
DOI 
https://doi.org/10.1136/jim-2022-002467
PubMed 
35853670

Print ISSN 
1081-5589
Online ISSN 
1708-8267
History 
  • Accepted June 1, 2022
  • Published online October 3, 2022.

Article Versions

  • Previous version (July 19, 2022 - 08:25).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The interpretation and reporting of these data are the responsibility of the authors and in no way should be viewed as official policy or interpretation of the Department of Veterans Affairs or the US government.Peter Van Buren is an Associate Editor; please add the disclosure to the competing interests statement.Final comment from a reviewer (please check with the authors at the galley stage):"In discussion there is just a sentence with typo that needs fixing: "Our exploratory results generate hypotheses that subclinical changes in cardiovascular parameters that may exist in patients with CKD stages 1-3."I believe extra word "that" should be removed."

Author Information

  1. L Parker Gregg1,2,3,
  2. Peter N Van Buren4,5,
  3. David J Ramsey3,
  4. Amaris Maydon6,
  5. Subhash Banerjee7,8,
  6. Carl P Walther1,
  7. Salim S Virani3,9,10,
  8. Wolfgang C Winkelmayer1,
  9. Sankar D Navaneethan1,2,3,11,
  10. S Susan Hedayati4
  1. 1 Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
  2. 2 Medical Care Line, Section of Nephrology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
  3. 3 Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA
  4. 4 Internal Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
  5. 5 Medical Service, Renal Section, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA
  6. 6 Mental Health Service, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA
  7. 7 Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
  8. 8 Medical Service, Cardiology Section, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA
  9. 9 Internal Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas, USA
  10. 10 Internal Medicine, Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
  11. 11 Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA
  1. Correspondence to Dr L Parker Gregg, Baylor College of Medicine Department of Medicine, Houston, Texas, USA; lucile.gregg{at}bcm.edu
View Full Text

Article usage

Article usage: July 2022 to July 2023

AbstractFullPdf
Jul 2022322122
Aug 2022259113
Sep 2022102113
Oct 2022268135
Nov 202212334
Dec 202210222
Jan 20232331
Feb 20233110
Mar 20233200
Apr 2023600
May 20232400
Jun 20231243
Jul 2023007

Statistics from Altmetric.com

PreviousNext
Back to top
Vol 70 Issue 7 Table of Contents
Journal of Investigative Medicine: 70 (7)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Front Matter (PDF)
Email

Thank you for your interest in spreading the word on JIM.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study
(Your Name) has sent you a message from JIM
(Your Name) thought you would like to see the JIM web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study
L Parker Gregg, Peter N Van Buren, David J Ramsey, Amaris Maydon, Subhash Banerjee, Carl P Walther, Salim S Virani, Wolfgang C Winkelmayer, Sankar D Navaneethan, S Susan Hedayati
Journal of Investigative Medicine Oct 2022, 70 (7) 1520-1528; DOI: 10.1136/jim-2022-002467

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study
L Parker Gregg, Peter N Van Buren, David J Ramsey, Amaris Maydon, Subhash Banerjee, Carl P Walther, Salim S Virani, Wolfgang C Winkelmayer, Sankar D Navaneethan, S Susan Hedayati
Journal of Investigative Medicine Oct 2022, 70 (7) 1520-1528; DOI: 10.1136/jim-2022-002467
Download PDF

Share
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study
L Parker Gregg, Peter N Van Buren, David J Ramsey, Amaris Maydon, Subhash Banerjee, Carl P Walther, Salim S Virani, Wolfgang C Winkelmayer, Sankar D Navaneethan, S Susan Hedayati
Journal of Investigative Medicine Oct 2022, 70 (7) 1520-1528; DOI: 10.1136/jim-2022-002467
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Data availability statement
    • Ethics statements
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Opium may affect coronary artery disease by inducing inflammation but not through the expression of CD9, CD36, and CD68
  • Bronchodilatory effect of higenamine as antiallergic asthma treatment
  • Evaluating reporting of patient-reported outcomes in randomized controlled trials regarding inflammatory bowel disease: a methodological study
Show more Original research

Similar Articles

 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Subscribe
  • Thank you to our reviewers
  • American Federation for Medical Research

AUTHORS

  • Information for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2023 American Federation for Medical Research